Medicef
CephradineAntibacterial
Indication:
Medicef (Cefradine) is
indicated for the treatment of the following infections when caused by
susceptible organisms:
The upper and lower respiratory tract
infections: Pharyngitis, sinusitis, otitis media, tonsillitis,
laryngo-tracheo-bronchitis, acute and chronic bronchitis, lobar and chronic
bronchopneumonia.
Urinary tract infections: Cystitis,
urethritis, pyelonephritis.
Skin and soft tissue infections: abscess, cellulitis, furunculosis and
impetigo.
Surgical prophylaxis: Surgical
procedures associated with high risk of disastrous consequences of infections. Medicef is also of value where
postoperative infections would be disastrous and where patients have a reduced
host resistance to bacterial infection. Protection is best ensured by achieving
adequate local tissue concentrations at the time when contaminations are likely
to occur. Thus, Medicef should be
administered immediately prior to surgery and continued during the
postoperative period.
Dosage & Administration:
Medicef may be given
regardless of meal.
Adults
Oral: The usual dose is 1-2 gm daily
in 2 to 4 divided doses. In severe and chronic infection, the dose can be
increased upto 4 gm daily which should be given in equally divided doses.
In skin and skin structure infections and respiratory tract infections: Usual
dose is 250 mg every 6 hours or 500 mg every 12 hours.
In Lobar pneumonia: Usual dose is 500
mg every 6 hours or 1g every 12 hours.
In uncomplicated urinary tract
infections: Usual dose is 500 mg every 12 hours. In more serious urinary
tract infections including prostatitis, 500 mg every 6 hours or 1 g every 12
hours may be administered.
Children
Oral: The usual dose is 25-50 mg/kg/day total, given in 2 or 4 equally divided
doses. For otitis media daily dose from 75-100 mg/kg body wt. in divided doses
every 6 to 12 hours are recommended. Dose may be increased up to 4 g/day
depending on the severity of the infection.
Elderly
There are no specific dosage recommendations or precautions for use in the
elderly except as with other drugs to monitor those patients with impaired
renal or hepatic functions.
Dosage in renal impairment
A modified dosage schedule is necessary in patients with decreased renal
function. Each patient should be considered individually. The following
modified dosage schedule is recommended as a guideline, based on creatinine
clearance. In adults, the initial loading dose is 750 mg of Cephradine and the
maintenance dose is 500 mg at the following intervals:
Preparation:
Medicef 500 Capsule: Each capsule contains Cephradine USP 500 mg.
Medicef Dry Powder: Each 5 ml suspension contains Cephradine USP 125 mg.